Lv65
2780 积分 2024-05-21 加入
Exploring the next generation of antibody–drug conjugates
2天前
已完结
Recent advances in function-enhanced antibody-drug conjugates: Antibody optimization and payload combination
2天前
已完结
Reduction of monoclonal antibody viscosity using interpretable machine learning
3天前
已完结
A bispecific nanobody-drug conjugate targeting TROP2 and c-Met for low-concentration, single-dose treatment of pancreatic cancer
19天前
已完结
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
28天前
已完结
‘Anticalins’: a new class of engineered ligand-binding proteins with antibody-like properties
29天前
已完结
Antibodies to watch in 2024
1个月前
已完结
Antibodies to watch in 2025
1个月前
已完结
Antibodies to watch in 2026
1个月前
已完结
Antibody–Drug Conjugates Drug Product Formulation and Process Development, Scalability and Stability Considerations
1个月前
已完结
皖公网安备34019202002308
